The association between the health of the intestines and the human body with Akkermansia muciniphila
Seyed Ali Sadr Tabatabaei,
No information about this author
Hedie Yousefi Ghadim,
No information about this author
Sara Alaei
No information about this author
et al.
The Microbe,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100352 - 100352
Published: April 1, 2025
Language: Английский
Exploratory Analysis of Gut Microbiota Profile in Duchenne Muscular Dystrophy (DMD) Patients with Intellectual Disability
Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 5, 2025
Abstract
This
study
investigates
the
differences
in
gut
microbiota
composition
between
DMD
patients
with
(DMD
+)
and
without
−)
intellectual
disability
(ID)
its
potential
role
cognitive
outcomes.
In
this
study,
we
assessed
50
genetically
confirmed
(median
age
13.1
years)
using
16S
rRNA
gene
sequencing.
Cognitive
assessment
was
performed
Wechsler
Intelligence
Scales,
ID
defined
as
an
IQ
<
70.
Stool
samples
were
analyzed,
statistical
methods
used
to
assess
alpha-
beta-diversity.
Thirty-four
percent
of
had
ID.
No
significant
found
alpha-diversity
or
Firmicutes/Bacteroidetes
ratio.
However,
beta-diversity
analysis
revealed
+
−
groups,
including,
,
increased
abundance
Propionibacterium
Bifidobacterium
a
reduction
Bulleidia
.
These
bacteria
are
involved
metabolic
pathways
that
can
influence
neurological
health
through
gut-brain
axis,
particularly
via
production
short-chain
fatty
acids.
While
these
preliminary
findings
suggest
possible
association
profile
impairment
DMD,
further
research
is
needed
explore
causal
relationship
consider
microbiota-targeted
therapeutic
strategies.
Language: Английский
Gastric emptying time and its correlation with cardiac MIBG in body-first and brain-first subtype Parkinson’s disease
Journal of Neurology,
Journal Year:
2024,
Volume and Issue:
272(1)
Published: Dec. 12, 2024
Language: Английский
Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression
Neural Regeneration Research,
Journal Year:
2024,
Volume and Issue:
20(12), P. 3416 - 3429
Published: Dec. 16, 2024
Parkinson’s
disease
has
long
been
considered
a
disorder
that
primarily
affects
the
brain,
as
it
is
defined
by
dopaminergic
neurodegeneration
in
substantia
nigra
and
brain
accumulation
of
Lewy
bodies
containing
α-synuclein
protein.
In
recent
decades,
however,
accumulating
research
revealed
also
involves
gut
uncovered
an
intimate
important
bidirectional
link
between
gut,
called
“gut–brain
axis.”
Numerous
clinical
studies
demonstrate
dysfunction
frequently
precedes
motor
symptoms
patients,
with
findings
including
impaired
intestinal
permeability,
heightened
inflammation,
distinct
microbiome
profiles
metabolites.
Furthermore,
deposition
consistently
observed
suggesting
potential
role
initiation.
Importantly,
individuals
vagotomy
have
reduced
risk.
From
these
observations,
researchers
hypothesized
may
initiate
subsequently
propagate
to
central
neurons
through
gut–brain
axis,
leading
disease.
This
review
comprehensively
examines
gut’s
involvement
disease,
focusing
on
concept
gut-origin
for
We
examine
interplay
altered
gut-related
factors
pathological
patients.
Given
accessibility
both
dietary
pharmacological
interventions,
targeting
gut-localized
represents
promising
avenue
developing
effective
therapies.
Language: Английский
Exploring the relationship betweenGBA1host genotype and gut microbiome in theGBA1L444P/WTmouse model: Implications for Parkinson disease pathogenesis
Elisa Menozzi,
No information about this author
Mallia Geiger,
No information about this author
Victoria Meslier
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 15, 2024
Abstract
Background
Heterozygous
variants
in
GBA1
are
the
commonest
genetic
risk
factor
for
Parkinson
disease
(PD)
but
penetrance
is
incomplete.
dysfunction
can
cause
gastrointestinal
disturbances
and
microbiome
changes
preclinical
models.
Mounting
evidence
suggests
that
microbiota-gut-brain
axis
potentially
implicated
PD
pathogenesis.
Whether
gut
composition
influenced
by
host
genetics
heterozygosis
has
never
been
explored.
Objectives
To
evaluate
whether
heterozygosity
pathogenic
L444P
variant
perturbations
composition.
Methods
Faecal
samples
collected
from
L444P/WT
WT/WT
mice
at
3
6
months
of
age
were
analysed
through
shotgun
metagenomic
sequencing.
Results
No
differences
α-
β-diversity
detected
between
genotyped
groups,
either
time
points.
Overall,
we
found
a
little
variation
functional
potential
over
time.
Conclusion
Host
genotype
does
not
impact
structure
presented
mouse
model.
Studies
investigating
effect
second
hit
on
physiology
could
explain
partial
PD.
Language: Английский
Comparison of vagus nerve cross-sectional area between brain-first and body-first Parkinson’s disease
Shuangshuang Dong,
No information about this author
Bo Shen,
No information about this author
Xu Jiang
No information about this author
et al.
npj Parkinson s Disease,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: Dec. 5, 2024
The
vagus
nerve
(VN)
is
the
main
neural
pathway
linking
gut
and
brain
in
Parkinson's
disease
(PD).
In
this
study,
we
utilized
high-resolution
ultrasound
to
measure
VN
cross-sectional
area
(CSA)
96
healthy
controls
(HCs)
75
PD
patients.
group
was
further
categorized
into
three
subgroups:
PD-preRBD,
PD-postRBD,
PD-nonRBD.
PD-preRBD
body-first
subtype,
PD-postRBD
PD-nonRBD
were
brain-first
subtype.
had
a
significantly
lower
CSA
than
HCs.
Subgroup
analysis
revealed
that
tended
exhibit
smaller
both
groups.
CSA,
specifically
right
VN,
correlated
with
subtype
some
components
of
PD-related
assessment
scales.
Overall,
these
findings
provide
evidence
atrophy
PD,
especially
suggesting
could
serve
as
an
adjunctive
diagnostic
tool.
Language: Английский